Institutional Ownership
Denali Therapeutics Inc
CUSIP 24823R105COMDNLIQ1 2026
Institutional Holders
260
13F filers
Shares Held
133.97M
Aggregate institutional
Institutional Value
$2.34B
Q1 2026
Net New Holders
+17
46 new · 29 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions46
Increased105
Decreased57
Sold out29
Institutional Holders
260 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 13.03M | $250.26M | +319.2K | Added |
| 2 | Baillie Gifford & Co | 12.07M | $231.68M | −244.4K | Reduced |
| 3 | Temasek Holdings (Private) Ltd | 7.01M | $134.65M | 0 | Held |
| 4 | State Street Corp | 6.27M | $120.42M | +8.6K | Added |
| 5 | Fmr LLC | 4.58M | $87.85M | −1.52M | Reduced |
| 6 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 4.43M | $85.10M | −551.4K | Reduced |
| 7 | Goldman Sachs Group Inc | 4.41M | $84.62M | +571.5K | Added |
| 8 | Baker Bros. Advisors LP | 3.73M | $71.65M | 0 | Held |
| 9 | Geode Capital Management, LLC | 3.73M | $71.58M | +269.0K | Added |
| 10 | Holocene Advisors, LP | 3.20M | $61.35M | +42.7K | Added |
250 more institutional holders on Premium
See every fund holding Denali Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders